These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 28707541

  • 41. Concurrent chemoradiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer.
    Toita T, Moromizato H, Ogawa K, Kakinohana Y, Maehama T, Kanazawa K, Murayama S.
    Gynecol Oncol; 2005 Mar; 96(3):665-70. PubMed ID: 15721409
    [Abstract] [Full Text] [Related]

  • 42. Platinum-based combination chemotherapy vs. weekly cisplatin during adjuvant CCRT in early cervical cancer with pelvic LN metastasis.
    Lee YY, Park W, Huh SJ, Yoon A, Park JY, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.
    Anticancer Res; 2013 Oct; 33(10):4675-81. PubMed ID: 24123048
    [Abstract] [Full Text] [Related]

  • 43. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC, Ho ES, Jan JS, Yang CH, Liu FS.
    Gynecol Oncol; 1996 Apr; 61(1):101-8. PubMed ID: 8626094
    [Abstract] [Full Text] [Related]

  • 44. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
    Gandhi AK, Sharma DN, Rath GK, Julka PK, Subramani V, Sharma S, Manigandan D, Laviraj MA, Kumar S, Thulkar S.
    Int J Radiat Oncol Biol Phys; 2013 Nov 01; 87(3):542-8. PubMed ID: 24074927
    [Abstract] [Full Text] [Related]

  • 45. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results.
    Liang JA, Chen SW, Chang WC, Hung YC, Yeh LS, Yang SN, Lin FJ.
    Clin Oncol (R Coll Radiol); 2008 Nov 01; 20(9):683-90. PubMed ID: 18676129
    [Abstract] [Full Text] [Related]

  • 46. Definitive altered fractionation radiotherapy and concomitant weekly cisplatin for locally advanced head and neck cancer.
    Boulmay BC, Chera BS, Morris CG, Kirwan J, Riggs CE, Lawson M, Mendenhall WM.
    Am J Clin Oncol; 2009 Oct 01; 32(5):488-91. PubMed ID: 19528791
    [Abstract] [Full Text] [Related]

  • 47. Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy.
    Mourad WF, Hu KS, Puckett L, Hauerstock D, Shourbaji RA, Li Z, Manolidis S, Schantz S, Tran T, Jacobson A, Urken M, Culliney B, Persky M, Harrison LB.
    Am J Clin Oncol; 2014 Feb 01; 37(1):57-62. PubMed ID: 23357967
    [Abstract] [Full Text] [Related]

  • 48. Weekly versus three-weekly cisplatin as an adjunct to radiation therapy in high-risk stage I-IIA cervical cancer after surgery: a randomized comparison of treatment compliance.
    Chumworathayi B, Suprasert P, Charoenkwan K, Srisomboon J, Phongnarisorn C, Siriaree S, Cheewakriangkrai C, Tantipalakorn J, Kiatpeerakul C, Pantusart A.
    J Med Assoc Thai; 2005 Nov 01; 88(11):1483-92. PubMed ID: 16471090
    [Abstract] [Full Text] [Related]

  • 49. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
    Borowsky ME, Elliott KS, Pezzullo JC, Santoso P, Choi W, Choi K, Abulafia O.
    Bull Cancer; 2005 Feb 01; 92(2):E19-24. PubMed ID: 15749639
    [Abstract] [Full Text] [Related]

  • 50. Concurrent Cisplatin-Based Chemoradiation in Squamous Cell Carcinoma of Cervix.
    Hashmi H, Maqbool A, Ahmed S, Ahmed A, Sheikh K, Ahmed A.
    J Coll Physicians Surg Pak; 2016 Apr 01; 26(4):302-5. PubMed ID: 27097702
    [Abstract] [Full Text] [Related]

  • 51. Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.
    Yoon MS, Chung WK, Ahn SJ, Nam TK, Nah BS, Song JY, Lim SC, Lee JK.
    Acta Otolaryngol; 2008 May 01; 128(5):590-6. PubMed ID: 18421617
    [Abstract] [Full Text] [Related]

  • 52. A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m2 cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors.
    Isohashi F, Takano T, Onuki M, Arimoto T, Kawamura N, Hara R, Kawano Y, Ota Y, Inokuchi H, Shinjo H, Saito T, Fujiwara S, Sawasaki T, Ando K, Horie K, Okamoto H, Murakami N, Hasumi Y, Kasamatsu T, Toita T.
    Int J Clin Oncol; 2019 May 01; 24(5):575-582. PubMed ID: 30580379
    [Abstract] [Full Text] [Related]

  • 53. Weekly cisplatin chemotherapy dosing versus triweekly chemotherapy with concurrent radiation for head and neck squamous cell carcinoma.
    Morse RT, Ganju RG, TenNapel MJ, Neupane P, Kakarala K, Shnayder Y, Chen AM, Lominska CE.
    Head Neck; 2019 Aug 01; 41(8):2492-2499. PubMed ID: 30856297
    [Abstract] [Full Text] [Related]

  • 54. Concurrent chemo-irradiation with weekly cisplatin and paclitaxel in the treatment of locally advanced squamous cell carcinoma of cervix: a phase II study.
    Varghese SS, Ram TS, Pavamani SP, Thomas EM, Jeyaseelan V, Viswanathan PN.
    J Cancer Res Ther; 2014 Aug 01; 10(2):330-6. PubMed ID: 25022387
    [Abstract] [Full Text] [Related]

  • 55. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC, Wang L, Lin JC, Jan JS.
    J Formos Med Assoc; 2015 Mar 01; 114(3):231-7. PubMed ID: 25777974
    [Abstract] [Full Text] [Related]

  • 56. Outcomes and prognostic factors of cervical cancer after concurrent chemoradiation.
    Kim TE, Park BJ, Kwack HS, Kwon JY, Kim JH, Yoon SC.
    J Obstet Gynaecol Res; 2012 Nov 01; 38(11):1315-20. PubMed ID: 22612778
    [Abstract] [Full Text] [Related]

  • 57. Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma.
    Fayette J, Molin Y, Lavergne E, Montbarbon X, Racadot S, Poupart M, Ramade A, Zrounba P, Ceruse P, Pommier P.
    Drug Des Devel Ther; 2015 Nov 01; 9():6203-10. PubMed ID: 26648696
    [Abstract] [Full Text] [Related]

  • 58. Phase I study of concurrent selective lymph node late-course accelerated hyperfractionated radiotherapy and S-1 plus cisplatin for locally advanced oesophageal squamous cell carcinoma.
    Li M, Fu C, Zhang W, Huang W, Wang Z, Zhou T, Lin H, Li B.
    Br J Radiol; 2016 Nov 01; 89(1060):20150476. PubMed ID: 26891913
    [Abstract] [Full Text] [Related]

  • 59. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Gynecol Oncol; 2008 Jan 01; 108(1):195-200. PubMed ID: 17963825
    [Abstract] [Full Text] [Related]

  • 60. Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
    Zhang J, Chen S, Li G, Zhang W, Qin T, Yin P, Huang H, Jiang H.
    Cancer Chemother Pharmacol; 2017 Jun 01; 79(6):1087-1097. PubMed ID: 28429051
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.